Torrent Pharma net profit rises 7 percent at Rs 378 crore in Q1

The company had reported a profit after tax (PAT) of Rs 354 crore in the year-ago quarter.

Revenue for the first quarter of the current fiscal rose to Rs 2,591 crore as against Rs 2,347 crore in the year-ago period, Torrent Pharma said in a statement.

The drug firm said its domestic revenue grew 14.5 percent year-on-year to Rs 1,426 crore during the quarter.

The company said its revenue also went up in Brazil and Germany by three percent and 21 percent, respectively.

Revenue in the US market, however, declined by two percent to Rs 293 crore, it added.

Read also: Torrent Pharma unveils generic version of Keveyis tablets in US

Torrent Pharma is an Indian multinational pharmaceutical company headquartered in Ahmedabad, India. The company specializes in the therapeutic segments of cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology, and anti-infective segments. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent Pharma has a widespread global presence in over 40 countries.

Read also: Torrent Pharma posts PAT at Rs 287 crore in Q4